@WeeZuhl, posted on another board but pertains to this company as well.
I'd like your assessment of this post.
---------------------------------------------------------------
With the herd already jumping over the gate.
Things are getting restless. Remdesivir will provide courage. But will the insurers pay for it? Other drugs?
"If the Brits are successful then the FDA should get that vaccine fast tracked over here ASAP"
But will they? What if the Chinese beats everyone to a vaccine?
The current vaccine debate centers around:
A study that says the virus can undergo recombination, and faster than a vaccine can be produced. More easily transmitted, and more virulent. Where this group says forget about a vaccine, and concentrate on drugs.
vs
A vaccine that has multiple "B-cell" epitopes. Where even if the virus mutates against a few, the remaining targets of the vaccine will still be there to stimulate immunity.
News 
Market Data 
Discover 
